Recently, Belgium's well-known 3D printing company Materialise announced that it has signed an agreement with Canon Lifecare Solutions to distribute Materialise's Mimics Innovation and Mimics Care software solutions in Japan. Under the agreement, workstations and 3D printer users from Canon Care Solutions will benefit from Materialise's open and flexible software solutions. Also included in the distribution agreement is Materialise's latest Mimics inPrint, which links all modern medical imaging system data to 3D printers or 3D printing service providers on the market, enabling clinicians to work directly in hospitals. 3D printing. Through Mimics Care Suite, Materialise is effectively integrating various medical software and services (whether new or existing) into a single, neutral platform that facilitates 3D planning and 3D printing in hospitals. Further integration. In addition, the Materialise Mimics Care kit includes software for predictive planning and communication, surgical guide manufacturing tools, organ models to help doctors complete complex procedures, and implant 3D printing software tools. Hilde Ingelaere, Executive Vice President of Materialise, said: "At Materialise, we have been investing in more than 25 years to discover meaningful 3D printing technology applications, develop software and solutions, and successfully bring them to market. And, we Especially optimistic about the application prospects of 3D printing in the field of medicine, we have a common vision with Canon care solutions. By distributing our software, Canon care solutions will help medical customers better integrate 3D printing into their Workflow and achieving cost savings can improve the patient care experience." Canon Care Solutions is part of Canon Inc., a medical device trader that sells imaging diagnostic equipment and infection control equipment to hospitals and clinics, as well as automated drug dosing and packaging equipment for pharmaceutical companies. Canon Care Solutions has extensive experience and technology in medical imaging services. In addition, they also provide 3D workstations to domestic customers in Japan. POCT system is a diagnostic system that using fluorescence immunoassay to quantify analysts
diseases and hormonal disorder.
Poct System,Immunoassay Analyzer Poct,Hba1C Poct,Hormone Detection Changchun ZYF science and technology CO.,LTD , https://www.zyf-medical.com
with high sensitivity by measuring laser-induced epifluorescence of test cartridges. It can be
used to screen lifestyle-related diseases from cardiac diseases, cancers, diabetes, infectious
Canon will sell Materialise in Japan to develop software for medical 3D printing
1. Introduction
1.1 Intended Use
CE:
Getein1100 lmmunofluorescence Quantitative Analyzer (hereinafter called Getein1100)
is an analyzer for processing and analysis of Getein test kits including markers for cardio
vascular diseases, renal diseases, inflammation, fertility, diabetes mellitus, bone metabo
lism, tumor and thyroid. This manual contains instructions for the use of Getein1100 and
general instructions for testing specimens and quality control materials
1.2 Product Description
Getein1100 is used to measure concentration of biomarkers in human whole blood,
serum, plasma or urine samples. The results can be used as an aid in clinical diagnosis
of laboratory and point of care testing.
1.3 Product Principle
1.3.1 Overview: Running a test
Apply sample (for example, serum) to the test card, insert the test card into the
Getein1100 after a certain time (outside mode) or immediately (inside mode) and click
"Start" icon. Then the concentration of this sample will be measured and the result will be
displayed (Fig.1-1). The test results can be transmitted to the lab or hospital information
system (LIS or HIS) when connected to computer.